Genetic susceptibility to lung cancer--light at the end of the tunnel?
- PMID: 23349013
- PMCID: PMC3581605
- DOI: 10.1093/carcin/bgt016
Genetic susceptibility to lung cancer--light at the end of the tunnel?
Abstract
Lung cancer is one of the most common and deadliest cancers in the world. The major socio-environmental risk factor involved in the development of lung cancer is cigarette smoking. Additionally, there are multiple genetic factors, which may also play a role in lung cancer risk. Early work focused on the presence of relatively prevalent but low-penetrance alterations in candidate genes leading to increased risk of lung cancer. Development of new technologies such as genomic profiling and genome-wide association studies has been helpful in the detection of new genetic variants likely involved in lung cancer risk. In this review, we discuss the role of multiple genetic variants and review their putative role in the risk of lung cancer. Identifying genetic biomarkers and patterns of genetic risk may be useful in the earlier detection and treatment of lung cancer patients.
Similar articles
-
Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium.Carcinogenesis. 2012 May;33(5):1059-64. doi: 10.1093/carcin/bgs116. Epub 2012 Mar 1. Carcinogenesis. 2012. PMID: 22382497 Free PMC article.
-
Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.Lung Cancer. 2006 Dec;54(3):267-83. doi: 10.1016/j.lungcan.2006.08.009. Epub 2006 Sep 18. Lung Cancer. 2006. PMID: 16982113 Review.
-
Genetic basis for susceptibility to lung cancer: Recent progress and future directions.Adv Cancer Res. 2010;109:51-72. doi: 10.1016/B978-0-12-380890-5.00002-8. Adv Cancer Res. 2010. PMID: 21070914 Review.
-
Genetic risk profiles for cancer susceptibility and therapy response.Recent Results Cancer Res. 2007;174:19-36. doi: 10.1007/978-3-540-37696-5_2. Recent Results Cancer Res. 2007. PMID: 17302182 Review.
-
Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.Int J Med Sci. 2007 Feb 1;4(2):59-71. doi: 10.7150/ijms.4.59. Int J Med Sci. 2007. PMID: 17299578 Free PMC article. Review.
Cited by
-
Regulation of MAPKs Signaling Contributes to the Growth Inhibition of 1,7-Dihydroxy-3,4-dimethoxyxanthone on Multidrug Resistance A549/Taxol Cells.Evid Based Complement Alternat Med. 2016;2016:2018704. doi: 10.1155/2016/2018704. Epub 2016 Jun 15. Evid Based Complement Alternat Med. 2016. PMID: 27403196 Free PMC article.
-
The contrasting roles of inflammasomes in cancer.Am J Cancer Res. 2018 Apr 1;8(4):566-583. eCollection 2018. Am J Cancer Res. 2018. PMID: 29736304 Free PMC article. Review.
-
Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population.Int J Cancer. 2017 Jan 15;140(2):329-336. doi: 10.1002/ijc.30447. Epub 2016 Oct 11. Int J Cancer. 2017. PMID: 27668986 Free PMC article.
-
Association between myeloperoxidase G-463A polymorphism and lung cancer risk.Tumour Biol. 2014 Jan;35(1):475-81. doi: 10.1007/s13277-013-1067-6. Epub 2013 Aug 14. Tumour Biol. 2014. PMID: 23943392
-
Association of education & lifestyle factors with the perception of genetic knowledge on the development of lung cancer.Indian J Med Res. 2016 May;143(Supplement):S32-S37. doi: 10.4103/0971-5916.191751. Indian J Med Res. 2016. PMID: 27748275 Free PMC article.
References
-
- Ferlay J, et al. GLOBOCAN 2009, Cancer incidence and mortality worldwide. IARC Scientific Publications No. 10, IARC, Lyon: Available from: http://globocan.iarc.fr (last accessed 1. December 2011).
-
- Jemal A., et al. (2010). Cancer statistics, 2010. CA. Cancer J. Clin., 60, 277–300 - PubMed
-
- Devesa S.S., et al. (2005). International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int. J. Cancer, 117, 294–299 - PubMed
-
- Owonikoko T.K., et al. (2007). Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J. Clin. Oncol., 25, 5570–5577 - PubMed
-
- Ramalingam S.S., et al. (2011). Lung cancer: new biological insights and recent therapeutic advances. CA. Cancer J. Clin., 61, 91–112 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical